Once the authorities approve your drug, there may be a need for safety evaluation in a real world setting. We conduct studies focused on safety outcomes/side effects/adverse events/complications. Through the linkage of multiple datasources we can provide a clear picture of the use of care and the short- and long-term effects on the patient’s health. The selection of linked databases fully depends on your specific research questions. If you would like to discuss the possibilities in detail, please contact us.
AMI: Acute myocardial infarction; EPS: Extrapyrimidal symptoms; HR: Hazard rate. Ref. Heintjes E, Overbeek J, Penning-van Beest F, et al. Post authorization safety study comparing quetiapine to risperidone and olanzapine. Pharmacoepidemiol Drug Saf, 2013; 22 (S1): 90